Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Short Interest

View and export this data going back to 2021. Start your Free Trial

What is Inspira Technologies Oxy BHN Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Inspira Technologies Oxy BHN's Short Interest

For the Medical Devices subindustry, Inspira Technologies Oxy BHN's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inspira Technologies Oxy BHN's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspira Technologies Oxy BHN's Short Interest distribution charts can be found below:

* The bar in red indicates where Inspira Technologies Oxy BHN's Short Interest falls into.

Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspira Technologies Oxy BHN Ltd (NAS:IINN) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ha-Tidhar Street, Ra'anana, ISR, 4366504

Website

http://www.inspira-technologies.com

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.